Instead, glioma-associated oncogene 1 (GLI1) and oligodendrocyte lineage transcription factor 2 (OLIG2), the expression of which is highly associated with glioma and GSCs [29], were upregulated (Fig. 2e). This evidence concerns the gene GLI1 and central nervous system cancer.